Addex Therapeutics Ltd Increase Decrease Through Exercise Of Warrants Equity
Addex Therapeutics Ltd (ADXN) reported Increase Decrease Through Exercise Of Warrants Equity of CHF 35.98 thousand for the 12-month period ending 2023-12-31, per its 20-F filed 2025-05-15.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity · last filed 2025-05-15
- Addex Therapeutics Ltd increase decrease through exercise of warrants equity for the quarter ending 2023-06-30 was 39.00 CHF.
| Period end | Increase Decrease Through Exercise Of Warrants Equity 3 month | Increase Decrease Through Exercise Of Warrants Equity 6 month | Increase Decrease Through Exercise Of Warrants Equity 12 month |
|---|---|---|---|
| 2023-12-31 | 35.98K CHF 20-F · filed 2025-05-15 | ||
| 2023-06-30 | 39.00 CHF 6-K/A · filed 2023-12-21 | 39.00 CHF 6-K/A · filed 2023-12-21 | |
| 2022-12-31 | 25.24K CHF 20-F · filed 2025-05-15 |